Clinical Trial Update: Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Glumetinib in combination with Nab-docetaxel for advanced gastric/gastroesophageal junction cancers and other solid tumors; cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Docetaxel (nanoparticle albumin-bound) (docetaxel)
• Glumetinib

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors | Phase 2 | Status: RECRUITING